FR2720277B1 - Méthode de traitement des cancers par régulation de la protéine P53. - Google Patents

Méthode de traitement des cancers par régulation de la protéine P53.

Info

Publication number
FR2720277B1
FR2720277B1 FR9406583A FR9406583A FR2720277B1 FR 2720277 B1 FR2720277 B1 FR 2720277B1 FR 9406583 A FR9406583 A FR 9406583A FR 9406583 A FR9406583 A FR 9406583A FR 2720277 B1 FR2720277 B1 FR 2720277B1
Authority
FR
France
Prior art keywords
protein
regulating
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9406583A
Other languages
English (en)
Other versions
FR2720277A1 (fr
Inventor
Jean-Marie Blanchard
Serge Carillo
Marc Piechaczyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9406583A priority Critical patent/FR2720277B1/fr
Priority to PCT/FR1995/000670 priority patent/WO1995033060A1/fr
Priority to JP8500420A priority patent/JPH10500978A/ja
Priority to AU26206/95A priority patent/AU714209B2/en
Priority to CA2190293A priority patent/CA2190293C/fr
Priority to EP95920973A priority patent/EP0763121A1/fr
Publication of FR2720277A1 publication Critical patent/FR2720277A1/fr
Application granted granted Critical
Publication of FR2720277B1 publication Critical patent/FR2720277B1/fr
Priority to NO19964772A priority patent/NO321411B1/no
Priority to FI964783A priority patent/FI120501B/fi
Priority to US09/405,920 priority patent/US20030060435A1/en
Priority to US10/788,489 priority patent/US7837991B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9406583A 1994-05-31 1994-05-31 Méthode de traitement des cancers par régulation de la protéine P53. Expired - Lifetime FR2720277B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR9406583A FR2720277B1 (fr) 1994-05-31 1994-05-31 Méthode de traitement des cancers par régulation de la protéine P53.
JP8500420A JPH10500978A (ja) 1994-05-31 1995-05-22 ｐ５３タンパク質の調節による腫瘍の治療方法
AU26206/95A AU714209B2 (en) 1994-05-31 1995-05-22 Method of cancer treatment by p53 protein control
CA2190293A CA2190293C (fr) 1994-05-31 1995-05-22 Methode de traitement des cancers par regulation de la proteine p53
EP95920973A EP0763121A1 (fr) 1994-05-31 1995-05-22 Methode de traitement des cancers par regulation de la proteine p53
PCT/FR1995/000670 WO1995033060A1 (fr) 1994-05-31 1995-05-22 Methode de traitement des cancers par regulation de la proteine p53
NO19964772A NO321411B1 (no) 1994-05-31 1996-11-11 Anvendelse av kalpastatin for fremstilling av et preparat for behandling av cancer
FI964783A FI120501B (fi) 1994-05-31 1996-11-29 p53-proteiinin pitoisuuksia säätelevien kalpaiinin aktiivisuuden inhibiittorien käyttö syöpälääkkeiden valmistuksessa
US09/405,920 US20030060435A1 (en) 1994-05-31 1999-09-24 Method of cancer treatment by p53 protein control
US10/788,489 US7837991B2 (en) 1994-05-31 2004-03-01 Method of cancer treatment by p53 protein control

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9406583A FR2720277B1 (fr) 1994-05-31 1994-05-31 Méthode de traitement des cancers par régulation de la protéine P53.

Publications (2)

Publication Number Publication Date
FR2720277A1 FR2720277A1 (fr) 1995-12-01
FR2720277B1 true FR2720277B1 (fr) 1996-07-12

Family

ID=9463670

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9406583A Expired - Lifetime FR2720277B1 (fr) 1994-05-31 1994-05-31 Méthode de traitement des cancers par régulation de la protéine P53.

Country Status (8)

Country Link
EP (1) EP0763121A1 (fr)
JP (1) JPH10500978A (fr)
AU (1) AU714209B2 (fr)
CA (1) CA2190293C (fr)
FI (1) FI120501B (fr)
FR (1) FR2720277B1 (fr)
NO (1) NO321411B1 (fr)
WO (1) WO1995033060A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518488C1 (de) * 1995-05-19 1996-10-10 Progen Biotechnik Gmbh Autoantigen, geeignet zur Feststellung einer Thromboseneigung
EP0799892A3 (fr) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, sa préparation et son utilisation
US6232454B1 (en) 1998-02-27 2001-05-15 Incyte Genomics, Inc. Human proteinase molecules
AU2344100A (en) * 1998-11-18 2000-06-05 Canji, Inc. Viral vectors with late transgene expression
WO2001074381A2 (fr) * 2000-03-31 2001-10-11 Parker Hughes Institute Inhibiteurs de calpaines pour le traitement du cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753665B2 (ja) * 1984-04-20 1995-06-07 財団法人癌研究会 抗転移剤
US5340922B1 (en) * 1988-05-31 1999-11-02 Mclean Hospital Corp Neural calcium-activated neutral proteinase inhibitors
EP0395309B1 (fr) * 1989-04-28 1995-12-27 Takara Shuzo Co. Ltd. Polypeptide semblable à la calpastatine humaine
JPH0641067A (ja) * 1992-04-20 1994-02-15 Kitasato Inst:The 新規カルパイン阻害物質ｋｐ−１２４１及びその製造法
EP0580161A1 (fr) * 1992-07-22 1994-01-26 THE McLEAN HOSPITAL CORPORATION Traitement prophylactique et thérapeutique de la maladie d'Alzheimer
US5607831A (en) * 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death

Also Published As

Publication number Publication date
CA2190293C (fr) 2011-06-28
FI964783A0 (fi) 1996-11-29
NO964772D0 (no) 1996-11-11
JPH10500978A (ja) 1998-01-27
CA2190293A1 (fr) 1995-12-07
FR2720277A1 (fr) 1995-12-01
AU714209B2 (en) 1999-12-23
NO321411B1 (no) 2006-05-08
NO964772L (no) 1996-11-11
FI120501B (fi) 2009-11-13
FI964783A (fi) 1996-11-29
WO1995033060A1 (fr) 1995-12-07
AU2620695A (en) 1995-12-21
EP0763121A1 (fr) 1997-03-19

Similar Documents

Publication Publication Date Title
DK0811110T3 (da) Oliekildebehandling
FI970918A (fi) Yhdisteet ja menetelmät syövän hoitamiseksi
FR2718037B1 (fr) Appareil de traitement de tumeur.
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
ATE231724T1 (de) Kombinationstherapie für die behandlung von psychosen
DE69612279D1 (de) Behandlung schwerer aromaten
DE69609868T2 (de) Neue steroidester zur behandlung von hauterkrankungen
AU3829895A (en) Methods for treating resistant tumors
IL118426A (en) Pharmaceutical composition containing 1,3- bis-triazolyl-2-propanol derivative for treating cancer tumors or viruses
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
FI974640A (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
AU3524995A (en) Method for treatment of cancers by regulating the activity of ras proteins
FR2720277B1 (fr) Méthode de traitement des cancers par régulation de la protéine P53.
FI973173A0 (fi) Menetelmä kondensaatin käsittelemiseksi
NO981822L (no) Anvendelse av proteinet GAX for behandling av cancer
FR2719240B1 (fr) Procédé de traitement des suspensions huileuses.
AU7602896A (en) Methods for treating resistant tumors
DE69601154D1 (de) Zubereitungen für die Behandlung von Hepatitis C
CA2294243A1 (fr) Nouvelles cyanoaziridines pour traiter le cancer
FI973521A (fi) Menetelmät munasarjasyövän inhiboimiseksi
DE69706195T2 (de) Antikonvulsive derivate zur behandlung von psoriasis
FR2671563B1 (fr) Procede de traitements metallurgiques.
FR2763933B1 (fr) Procede de preparation de zircons par traitement hydrothermique et zircons ainsi obtenus
EA199600050A3 (ru) Ионный источник.
BR1100558A (pt) famìlia de anticorpos modificados, com elevada afinidade, para tratamento de cáncer.

Legal Events

Date Code Title Description
CD Change of name or company name